Dr Holger Becker obtained his physics degrees from the University of Western Australia/Perth and the University of Heidelberg. He started to work on miniaturized systems for chemical analysis during his PhD thesis at Heidelberg University, where he obtained his PhD in Applied Physics in 1995. Between 1995 and 1997 he was a Research Associate at Imperial College with Prof. Andreas Manz. In 1998 he joined Jenoptik Mikrotechnik GmbH. Since then, he founded and led several companies in the field of microsystem technologies in medicine and the life sciences, for which he received various awards, most notably a nomination for the “Deutscher Gründerpreis” in 2004. He led the Industry Group of the German Physical Society between 2004 and 2009, and is the current chair of the SPIE ‘‘Microfluidics, BioMEMS and Medical Microsystems’’ conference, co-chair of MicroTAS 2013 and in the Industrial Committee for MicroTAS 2016 and 2017. He serves on the Advisory Board of “Lab-on-a-Chip”, the Editorial Boards of “Microelectronic Engineering” and “Micro and Nanosytems” as well as on the Board of Trustees of the “Physik Journal”. In 2014, he was appointed a Fellow of The Royal Society of Chemistry (London). He has published more than 160 journal and conference paper with currently >5.000 citations.
Before joining the Polytechnique Federale de Lausanne (EPFL) in Switzerland Juergen Brugger was connected to the MESA+ Research Institute of Nanotechnology at the University of Twente in the Netherlands, at the IBM Zurich Research Laboratory, and at the Hitachi Central Research Laboratory, in Tokyo, Japan. He received his Master in Physical-Electronics and his PhD degree from Neuchatel University, Switzerland.
Research in Juergen Brugger’s laboratory focuses on various aspects of MEMS and Nanotechnology. Over the past 15 years the group has made several important contributions to the field, at the fundamental level as well as in technological development, as demonstrated by the start-ups that spun off from the lab. In his research, key competences are in micro/nanofabrication, additive micro-manufacturing, new materials for MEMS for biomedical applications. Over the past 10 years, he published over 200 peer-refereed papers, supervised 20 PhD students. Former students and postdocs have been successful in receiving awards and starting their own scientific careers (6 professors so far). Juergen Brugger has been appointed in 2016 Fellow of the IEEE “For contributions to micro and nano manufacturing technology”.
Lorna Ewart obtained an honours degree in Pharmacology from the University of Aberdeen and a PhD from Sir John Vane’s William Harvey Research Institute, University of London. She joined the Respiratory and Inflammation research area within AstraZeneca as a lead biologist bringing forward projects to candidate drug nomination before moving into pre-clinical drug safety to lead a safety pharmacology team delivering across multiple therapeutic areas. Lorna Ewart spent two years in Gothenburg, Sweden as the therapy area lead toxicologist for Respiratory and Inflammation therapy area before returning to Cambridge, UK where she heads the Centre of Excellence for Microphyisological Systems within AstraZeneca’s Innovative Medicines Unit. Here she has established strategic collaborations with leading external academics as well as ensured technology transfer into AstraZeneca. Scientifically, Lorna Ewart is passionate about the translation of preclinical science to patient outcome. She has over 25 peer reviewed publications and is a fellow of the Royal Society of Biology and the British Pharmacological Society.
Prof. Frank Koppens obtained his PhD in experimental physics at Delft University, at the Kavli Institute of Nanoscience, The Nederlands. After a postdoctoral fellowship at Harvard University, since August 2010, Koppens is a group leader at the Institute of Photonic Sciences (ICFO). The quantum nano-optoelectronics group of Prof. Koppens focuses on both science and technology of
novel two-dimensional materials and quantum materials. Koppens has received four ERC grants, the Christiaan Hugyensprijs 2012, the Premis Nacional de Reserca, and the IUPAP young scientist prize in optics. Prof. Koppens is leader of the optoelectronics workpackage of the graphene flagship (1B€ project for 10 years).
Laura M. Lechuga is Full Professor at the Catalan Institute of Nanoscience and Nanotechnology (ICN2), Spanish National Research Council (CSIC) & CIBER-BBN. Since 2013 she is a Distinguished Visiting professor (PVE) at the Dept. of Microwaves and Photonics, School of Electrical and Computer Sciences, University of Campinas (Brazil) and Fellow of the Optical Society (OSA) since 2014.
The principal focus of her research program is the technological development of photonic (plasmonics and silicon-based) biosensors, their integration in portable lab-on-a-chip platforms and their application for clinical and environmental diagnostics.Prof. Laura Lechuga is associate editor of the IEEE Photonics Journal, associate editor of the J. Optics and Laser Technology (Elsevier) and is at the Editorial Board of the Journal of Nanobiosensors in Disease Diagnosis and of the Journal of Sensors.
Dr. Peter Loskill is head of the Fraunhofer Attract group Organ-on-a-Chip in the Department of Cell and Tissue Engineering at the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB) in Stuttgart, Germany. Dr. Loskill graduated in 2012 from Saarland University with a PhD in Physics focusing on Biointerface science. He then spent three years in the laboratory of Prof. K. E. Healy at the University of California at Berkeley. There, he worked as a postdoctoral fellow and project leader, funded by the NIH NCATS TissueChip program and the German Science Foundation, and developed organ-on-a-chip systems based on human iPS-cell technology. In 2015, he was named as one of Technology Review’s “Innovators under 35 Germany”. In 2016, he was awarded a Fraunhofer Attract Grant, the highest funded German starting grant program, which enabled him to start an independent research group at Fraunhofer IGB. His group focuses on the development of human iPS-cell based microphysiological Organ-on-a-chip Systems with applications in pharmaceutical research, toxicology screening, and mechanistic studies as well as on approaches for automatization and parallelization of these systems.
dr. Bert Jan Offrein is a principal research staff member at IBM Research in Zurich, Switzerland. He received his Applied Physics Master degree and Ph.D. in nonlinear integrated optics from the University of Twente, respectively in 1990 and 1994. Bert Jan then joined IBM Research – Zurich as a Post-Doctoral researcher, working on the design and characterisation of integrated optical devices for DWDM networks. In 1998, he changed to JDS Uniphase as a technical marketing and yield engineer for 980 nm pump lasers. One year later he returned to IBM Research – Zurich to lead the photonic device technology group realising state of the art adaptive integrated optical components. Since 2004, Bert Jan Offrein is the manager of the photonics group, addressing silicon photonics, electro-optic integration for system scaling and nano-photonic structures for quantum photonics.